Table-III.
Diagnostic & therapeutic delay (Lag-3 & Lag-4) with disease outcome.
Groups | Lag time | N% | DAS28 Mean ±SD | P-value | HAQ-DI Mean ±SD | P-value | |
---|---|---|---|---|---|---|---|
Lag-3 | Group 1 | ≤1 year | 60(58.8%) | 4.04±1.37 | 0.02 | 0.55±0.44 | 0.01 |
Group 2 | >1 year-<5 years | 19(18.6%) | 4.58±1.5 | 0.61±0.40 | |||
Group 3 | >5 years | 23(22.5%) | 5.01±1.65 | 0.87±0.48 | |||
Lag-4 | Group 1 | ≤1 year | 50(49%) | 3.9±1.42 | 0.01 | 0.499±0.44 | 0.00 |
Group 2 | >1 year-<5 years | 19(18.6%) | 4.5±1.32 | 0.66±0.38 | |||
Group 3 | >5 years | 33 (32.4) | 4.9±1.57 | 0.82±0.46 |
Annova was used to compare mean DAS28 & HAQ-DI between groups (group1-group3) for both lag3 and lag4 (p value<0.05 significant).